Related Experiment Video

Updated: Mar 29, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

5.9K

[Adherence to Therapy as a Factor Determining Prognosis of Coronary Artery Bypass Grafting]

S A Pomeshkina, I V Borovik, I N Zavyrylina

    Kardiologiia
    |December 1, 2015
    PubMed

    Insights

    Patient adherence to therapies after coronary artery bypass grafting (CABG) significantly impacts recovery. While medication use increased post-CABG, many patients still didn't meet secondary prevention goals.

    Area of Science:

    • Cardiovascular Surgery
    • Clinical Cardiology
    • Public Health

    Context:

    • Coronary Artery Bypass Grafting (CABG) is a major surgical intervention for stable coronary artery disease (CAD).
    • Postoperative patient adherence to recommended medical therapies is crucial for long-term outcomes.
    • Understanding adherence patterns is essential for improving secondary prevention strategies.

    Purpose:

    • To investigate the relationship between patient adherence to recommended therapies and postoperative outcomes following CABG.
    • To assess changes in modifiable cardiovascular risk factors and medication adherence before and after CABG.
    • To evaluate the achievement of secondary prevention goals one year after CABG.

    Summary:

    • This study examined 197 patients (age 38-75) undergoing CABG. Pre-surgery, adherence to medications like antiplatelet agents, beta-blockers, ACE inhibitors, and statins was low.
    • Post-CABG, medication adherence significantly improved, yet only half achieved secondary prevention targets. Modifiable risk factors like smoking and obesity showed limited improvement, with physical activity levels unchanged.

    Impact:

    • Findings highlight the need for enhanced patient education and support to improve adherence to secondary prevention strategies after CABG.
    • Improved adherence can potentially lead to better long-term prognosis and reduced cardiovascular events in post-CABG patients.
    • This research provides insights for healthcare providers to optimize postoperative care and patient management for coronary artery disease.
    Abstract

    More Related Videos

    Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery09:12

    Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery

    Published on: March 27, 2018

    10.0K
    Author Spotlight: Enhancing Coronary Artery Revascularization05:25

    Author Spotlight: Enhancing Coronary Artery Revascularization

    Published on: September 15, 2023

    1.4K

    Related Concept Videos

    Coronary Artery Disease V: Interprofessional Care01:27

    Coronary Artery Disease V: Interprofessional Care

    Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
    398
    Acute Coronary Syndrome III: Diagnostic Studies01:30

    Acute Coronary Syndrome III: Diagnostic Studies

    Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
    421
    Acute Coronary Syndrome IV: Interprofessional Care01:28

    Acute Coronary Syndrome IV: Interprofessional Care

    IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
    446
    Coronary Artery Disease IV: Preventive Measures01:26

    Coronary Artery Disease IV: Preventive Measures

    Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
    839
    Peripheral Artery Disease III: Interprofessional Care01:27

    Peripheral Artery Disease III: Interprofessional Care

    Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
    559
    Atherosclerosis III: Management01:26

    Atherosclerosis III: Management

    Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
    582